
Galenica has announced that it has entered into an agreement to acquire Relypsa in a deal worth $1.53 billion, which …

Troubles don’t seem to go away for Canada-based Valeant Pharma (NYSE: VRX) with news of a probable sale doing the …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

